BUZZ-U.S. STOCKS ON THE MOVE-Allergan, Mylan, BiolineRx, Fiat
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures fell sharply on Monday on concerns about China's slowing growth in the wake of the biggest drop in Shanghai shares in eight years. Dow Jones industrial average futures were down 0.61 percent at 17,416, S&P 500 futures were down 0.52 percent at 2,066.75 and Nasdaq 100 futures were down 0.69 percent at 4,530.5.
** TEVA PHARMACEUTICAL INDUSTRIES LTD, Friday close $61.85, +13.50 pct premarket
** ALLERGAN PLC, Friday close $308.21, +8.69 pct premarket
** MYLAN NV, Friday close $65.94, -13.18 pct premarket
Teva Pharmaceutical Industries has agreed to buy Allergan's generic drugs business for $40.5 billion in a deal that will turn Teva into one of the top 10 pharmaceutical companies.
Teva dropped its $40 billion bid for Mylan, which hit a snag when a Dutch foundation linked to Mylan bought temporary control of half the company in an attempt to block the takeover.
** BIOLINERX LTD, Friday close $2.12, -16.98 pct premarket
** BELLEROPHON THERAPEUTICS INC, Friday close $7.65 Continued...